¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08
±³À°ÀÏÀÚ : 2024-06-08
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ´ë¾çAI¼¾ÅÍ AIȦ / ÄÁÆÛ·±½º·ë 1~3

±³À°ÁÖÁ¦ : 2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ
´ã´çÀÚ : ÃÖÀº¿µ
¿¬¶ôó : 070-8873-6030  

À̸ÞÀÏ : k-iscp@kscvp.org

±³À°Á¾·ù : ³»°ú, ½Å°æ¿Ü°ú

Âü¼®¿¹»óÀÎ : 160¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 09:00~09:20 Beta blockers/Calcium channel blockers À±¹ÎÀç(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 09:20~09:40 Diuretics ¾ÈÈ¿¼® (°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 09:40~10:00 Statin/Fibrate/Omega-3 fatty acid ½Åµ¿È£(¿¬¼¼ÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 10:00~10:20 Inotropics & Vasopressors ÃÖÁ¤Çö( ºÎ»êÀÇ´ë ¼øȯ±â³»°ú )

Åä·Ð 06¿ù 08ÀÏ AIȦ 10:20~10:30 Åä·Ð ()

ÈÞ½Ä 06¿ù 08ÀÏ 10:30~10:50 ÈÞ½Ä ()

±³À°½Ã°£ 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 10:50~11:10 It's new, but it's not new anymore: RNA-based therapeutics for CVD À§Áø (°¡ÃµÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 11:10~11:30 Can RNA drugs be the game changers for dyslipidemia treatement ? ¹ÚÀçÇü(°í·ÁÀÇ´ë ¼øȯ±â³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 11:30~11:50 The world's first RNA interference drug: Patisiran in ATTR amyloidosis with cardiomyopathy ±è°æÈñ (ÀÎõ¼¼Á¾º´¿ø ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 11:50~12:10 Are there  even new RNA drugs for treating HTN ? Á¤¹ÌÇâ (°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú )

Åä·Ð 06¿ù 08ÀÏ ÄÁÆÛ·±½º·ë 1~3 12:10~12:20 Åä·Ð ()

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 10:50~11:10 Cancer induced thromboembolism È«Á¤¾Ö(ÇѸ²ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 11:10~11:30 Cancer and Heart Failure ¹ÚÁøÁÖ(¼­¿ïÀÇ´ë ½ÉÀåÇ÷°ü³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 11:30~11:50 Chemotherapy induced Cardiovascular adverse drug reaction È«¼Ò¿¬ (ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾àÁ¦ºÎ)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 11:50~12:10 Role of Pharmacist in Cardio-oncoloy À¯Áö¿¬(ÇѸ²´ë¼º½Éº´¿ø ¾àÁ¦ºÎ)

Åä·Ð 06¿ù 08ÀÏ AIȦ 12:10~12:20 Åä·Ð ()

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 12:20~12:40 Integrating Artificial Intelligence into Electrocardiography: A New Era of  Cardiology ¹é¿ë¼ö(ÀÎÇÏÀÇ´ë ½ÉÀå³»°ú)

½Ä»ç 06¿ù 08ÀÏ 12:40~13:30 ½Ä»ç ()

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 13:30~13:50 Overview: Current anti-obesity medication ¼­Àçºó(¼­¿ïÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 13:50~14:10 Weekly GLP-1 Receptor Agonist (Semaglutide) À̼¼Á¤(Â÷ÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 14:10~14:30 GLP-1/GIP Dual Agonist (Tirzepatide) õ´ë¿µ(ÇѸ²ÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 14:30~14:50 Upcoming drugs to conquer obesity Á¤Ã¢Èñ(¿ï»êÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 06¿ù 08ÀÏ AIȦ 14:50~15:00 Åä·Ð ()

ÈÞ½Ä 06¿ù 08ÀÏ 15:00~15:20 ÈÞ½Ä ()

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 15:20~15:40 Introduction of arterial stiffness ±èÇзÉ(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 15:40~16:00 Statin Á¤ÀçÈÆ(µ¿±¹ÀÇ´ë ¼øȯ±â³»°ú )

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 16:00~16:20 RAS blockers ½ÅÁ¤ÈÆ(ÇѾçÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 06¿ù 08ÀÏ AIȦ 16:20~16:40 Emerging drugs (sacubitril/valsartan and SGLT2 inhibitors) °ø¹Î±Ô(¼øõÇâÀÇ´ë ½ÉÀå³»°ú )

Åä·Ð 06¿ù 08ÀÏ AIȦ 16:50~17:00 Åä·Ð ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æÈñ´ëÇб³º´¿ø 2024 Kyung Hee Knee Symposium : 2024-06-08
´ÙÀ½±Û (¿Â¶óÀÎ) 2024³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ °¨¿°°ü¸®ÀÇ»ç ¿¬¼ö±³À° : 2024-06-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20820 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦31ȸ °³¿øÀǸ¦ À§ÇÑ ¿¬¼ö°­Á : 2024-06-16 0 4 2024-05-27
20819 ºÎ»ê ´ëÇÑÀ̽ÄÇÐȸ 2024³â ½ÅÀåÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-16 0 2 2024-05-27
20818 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-16 0 3 2024-05-27
20817 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ¾ð¾î°Ë»ç ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-06-16 0 1 2024-05-27
20816 ¼­¿ï Á¦28ȸ ¼­¿ï½Ã³»°úÀÇ»çȸ Á¤±âÃÑȸ ¹× Çмú´ëȸ : 2024-06-16 0 5 2024-05-27
20815 ¼­¿ï 2024³â Á¦16ȸ °æÈñ´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-16 0 0 2024-05-27
20814 ºÎ»ê 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿µ³²¼Ò¾Æ¾Ë·¹¸£±â ½ÉÆ÷Áö¿ò : 2024-06-16 0 2 2024-05-27
20813 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦23Â÷ ½Å»ý¾Æ¼Ò»ý¼ú workshop : 2024-06-16 0 0 2024-05-27
20812 ¼­¿ï 2024³â ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ ÀÇÇÐÀ¯ÀüÇÐ Primer Course : 2024-06-16 0 3 2024-05-27
20811 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 2 2024-05-27
20810 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°ú ÄÄÇ»Åͼö¼úÇÐȸ - Á¦3ȸ ±¹Á¦ ·Îº¿¼ö¼ú ½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
20809 °æ±â ´ëÇѺñ¸¸ÇÐȸ Á¦18ȸ ODOT (One Day Course of Obesity Treatment) : 2024-06-15 0 4 2024-05-27
20808 ¼­¿ï 2024³â Á¦ 1ȸ ºñ¸¸ ¿¬¼ö°­ÁÂ(ObesityCare Pro) : 2024-06-15 0 4 2024-05-27
20807 ¼­¿ï 2024 °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ½Å°æ¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 3 2024-05-27
20806 ¼­¿ï ´ëÇѼöºÎ¿Ü°úÇÐȸ ¼öºÎ»óÁö ÇÏ°èÇмú´ëȸ : 2024-06-15 0 3 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷